Photo of James E. Kendrick, MD

James E. Kendrick, MD

Obstetrician-gynecologist

Research Area:

Expertise of James E. Kendrick, MD

6 items. To interact with these items, press Control-Option-Shift-Right Arrow
Biography

Dr. James E Kendrick, MD, FACOG is board certified in gynecology oncologist in Orlando. Dr. Kendrick joined the Gynecologic Oncology Program at the Florida Hospital Cancer Institute in July of 2009. He graduated with honors from the University of Alabama School of Medicine. Dr. Kendrick then completed a four year residency in obstetrics and gynecology followed by a three year fellowship in gynecologic oncology at The University of Alabama at Birmingham. Dr. Kendrick is widely published in numerous academic journals, and currently serves as the principal investigator for all Gynecologic Oncology Group clinical trials available to our patients. His clinical interests include robotic surgery and the surgical and medical management of all gynecologic malignancies.

Education

University of Alabama School of Medicine, Birmingham, AL

Residency

University of Alabama at Birmingham, AL

Fellowship

University of Alabama at Birmingham, AL

Specialty

Gynecology Oncology

Board Certifications

American Board of Obstetrics & Gynecology

Publications of James E. Kendrick, MD
  • Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancer
    , INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

  • Clinical outcomes analysis of neoadjuvant chemotherapy for locally advanced vulvar cancer
    , GYNECOLOGIC ONCOLOGY

  • Analysis of "sandwich" chemo-radiation therapy for stage IIIC endometrial cancer
    , GYNECOLOGIC ONCOLOGY

    More sources loaded

  • Malignant peritoneal cytologic contamination with robotic hysterectomy for endometrial cancer
    , GYNECOLOGIC ONCOLOGY

  • Clinical Activity of Olvimulogene Nanivacirepvec-Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer The Nonrandomized Phase 2 VIRO-15 Clinical Trial
    , JAMA ONCOLOGY

  • MALIGNANT PERITONEAL CYTOLOGIC CONTAMINATION WITH ROBOTIC HYSTERECTOMY FOR ENDOMETRIAL CANCER
    , INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

  • Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial
    , CLINICAL CANCER RESEARCH

  • Corrigendum to "A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer" [Gynecologic Oncology 163 (2021) 481-489].
    , Gynecologic oncology

  • Search for Lepton-Flavor Violation in Z-Boson Decays with tau Leptons with the ATLAS Detector
    , PHYSICAL REVIEW LETTERS

  • A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer
    , GYNECOLOGIC ONCOLOGY